Adela Cañete Selected Research

Adela Cañete Research Topics

Disease

24	Neoplasms (Cancer) 04/2024 - 02/2009
22	Neuroblastoma 01/2023 - 03/2009
4	Neoplasm Metastasis (Metastasis) 05/2019 - 03/2009
3	Glioma (Gliomas) 01/2022 - 01/2018
1	Lymphoma (Lymphomas) 04/2024
1	Leukemia 04/2024
1	Hydrocephalus (Hydrocephaly) 01/2024
1	Cardiotoxicity 07/2023
1	Thrombocytopenia (Thrombopenia) 02/2023
1	Anemia 02/2023
1	Neutropenia 02/2023
1	Wilms Tumor (Wilm's Tumor) 11/2022
1	Sarcoma (Soft Tissue Sarcoma) 04/2021
1	Chromosome Breakage 01/2021
1	Paraganglioma (Paragangliomas) 01/2018
1	Pheochromocytoma 01/2018
1	Glioblastoma (Glioblastoma Multiforme) 01/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 11/2016
1	Osteosarcoma (Osteogenic Sarcoma) 01/2016
1	Ataxia (Dyssynergia) 01/2016
1	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 01/2016
1	Necrosis 07/2015
1	Retinoblastoma (Glioblastoma, Retinal) 01/2015
1	Teratocarcinoma 01/2015
1	Thalassemia 06/2014
1	Intellectual Disability (Idiocy) 06/2014
1	Chromosome Aberrations (Chromosome Abnormalities) 06/2014
1	Brain Neoplasms (Brain Tumor) 09/2013
1	Medulloblastoma 09/2013
1	Testicular Neoplasms (Testicular Cancer) 04/2009
1	Residual Neoplasm 04/2009

Drug/Important Bio-Agent (IBA)

5	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 09/2013
4	MicroRNAs (MicroRNA)IBA 07/2023 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2013
3	Biomarkers (Surrogate Marker)IBA 12/2020 - 01/2015
3	AntigensIBA 01/2016 - 04/2009
2	SolutionsIBA 01/2023 - 07/2022
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 06/2014
2	Cell-Free Nucleic AcidsIBA 01/2023 - 01/2023
2	RNA (Ribonucleic Acid)IBA 01/2022 - 07/2009
2	VitronectinIBA 10/2021 - 05/2019
2	Glycoproteins (Glycoprotein)IBA 10/2021 - 05/2019
2	Bevacizumab (Avastin)FDA Link 01/2020 - 01/2018
2	GlycosaminoglycansIBA 05/2018 - 02/2014
1	AnthracyclinesIBA 07/2023
1	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 02/2023
1	Circulating Tumor DNAIBA 01/2023
1	CCCTC-Binding FactorIBA 11/2022
1	Epidermal Growth Factor (EGF)IBA 01/2022
1	LigandsIBA 10/2021
1	Etoposide (VP 16)FDA LinkGeneric 10/2021
1	IntegrinsIBA 10/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2021
1	B7-H1 AntigenIBA 01/2021
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Angiogenesis InhibitorsIBA 01/2020
1	Histones (Histone)IBA 01/2020
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2019
1	Indicators and Reagents (Reagents)IBA 05/2018
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2018
1	olaparibIBA 11/2017
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2017
1	Immunoglobulin G (IgG)IBA 01/2016
1	Potassium Channels (Potassium Channel)IBA 01/2016
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2015
1	hydrogen sulfite (bisulfite)IBA 01/2015
1	X-linked Nuclear ProteinIBA 06/2014
1	Irinotecan (Camptosar)FDA LinkGeneric 09/2013
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2013
1	Proteasome InhibitorsIBA 01/2013
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2013
1	Monoclonal AntibodiesIBA 12/2010
1	AntibodiesIBA 12/2010
1	Genetic Markers (Genetic Marker)IBA 02/2009

Therapy/Procedure

16	Therapeutics 04/2024 - 07/2009
5	Drug Therapy (Chemotherapy) 03/2023 - 03/2009
4	Precision Medicine 02/2023 - 11/2016
2	Immunotherapy 01/2022 - 09/2017
2	Radiotherapy 01/2020 - 01/2018
1	Off-Label Use 04/2024
1	Ventriculostomy 01/2024
1	Combined Modality Therapy 01/2022
1	Induction Chemotherapy 09/2019
1	Investigational Therapies (Experimental Therapy) 09/2017
1	Aftercare (After-Treatment) 01/2017